ALX receptor ligands define a biochemical endotype for severe asthma.
作者信息
Ricklefs Isabell, Barkas Ioanna, Duvall Melody G, Cernadas Manuela, Grossman Nicole L, Israel Elliot, Bleecker Eugene R, Castro Mario, Erzurum Serpil C, Fahy John V, Gaston Benjamin M, Denlinger Loren C, Mauger David T, Wenzel Sally E, Comhair Suzy A, Coverstone Andrea M, Fajt Merritt L, Hastie Annette T, Johansson Mats W, Peters Michael C, Phillips Brenda R, Levy Bruce D
出版信息
JCI Insight. 2018 Mar 22;3(6):120932. doi: 10.1172/jci.insight.120932.
Abstract
摘要
相似文献
1
ALX receptor ligands define a biochemical endotype for severe asthma.ALX受体配体定义了重度哮喘的一种生化内型。
JCI Insight. 2018 Mar 22;3(6):120932. doi: 10.1172/jci.insight.120932.
2
Looking for Airways Periostin in Severe Asthma: Could It Be Useful for Clustering Type 2 Endotype?寻找严重哮喘中的气道骨膜蛋白：它是否可用于 2 型表型聚类？
Chest. 2018 Nov;154(5):1083-1090. doi: 10.1016/j.chest.2018.08.1032. Epub 2018 Oct 15.
3
The Complex Type 2 Endotype in Allergy and Asthma: From Laboratory to Bedside.过敏和哮喘的 2 型复杂表型：从实验室到床边。
Curr Allergy Asthma Rep. 2015 Jun;15(6):29. doi: 10.1007/s11882-015-0529-x.
4
IL4Rα and ADAM33 as genetic markers in asthma exacerbations and type-2 inflammatory endotype.IL4Rα和ADAM33作为哮喘急性加重和2型炎症内型的遗传标志物。
Clin Exp Allergy. 2017 Aug;47(8):998-1006. doi: 10.1111/cea.12927. Epub 2017 Apr 21.
5
The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo.脂氧素受体ALX：体内有效的配体特异性和立体选择性作用。
Pharmacol Rev. 2006 Sep;58(3):463-87. doi: 10.1124/pr.58.3.4.
6
Atopic endotype in childhood.儿童特应性表型。
J Allergy Clin Immunol. 2016 Mar;137(3):844-51.e4. doi: 10.1016/j.jaci.2015.10.004. Epub 2015 Nov 18.
7
The common promoter polymorphism rs11666254 downregulates FPR2/ALX expression and increases risk of sepsis in patients with severe trauma.常见启动子多态性 rs11666254 下调 FPR2/ALX 表达，增加严重创伤患者脓毒症风险。
Crit Care. 2017 Jul 6;21(1):171. doi: 10.1186/s13054-017-1757-3.
8
Characterization of the promoter and the transcriptional regulation of the lipoxin A4 receptor (FPR2/ALX) gene in human monocytes and macrophages.人单核细胞和巨噬细胞中脂氧素 A4 受体（FPR2/ALX）基因的启动子特征及其转录调控。
J Immunol. 2012 Feb 15;188(4):1856-67. doi: 10.4049/jimmunol.1101788. Epub 2012 Jan 13.
9
Eosinophilic Endotype of Asthma.哮喘的嗜酸性粒细胞亚型
Immunol Allergy Clin North Am. 2016 Aug;36(3):559-68. doi: 10.1016/j.iac.2016.03.006.
10
FPR2/ALX activation reverses LPS-induced vascular hyporeactivity in aorta and increases survival in a pneumosepsis model.FPR2/ALX激活可逆转脂多糖诱导的主动脉血管反应性降低，并提高肺炎脓毒症模型的存活率。
Eur J Pharmacol. 2015 Jan 5;746:267-73. doi: 10.1016/j.ejphar.2014.11.026. Epub 2014 Dec 2.
引用本文的文献
1
Soluble pattern recognition molecules: Guardians and regulators of homeostasis at airway mucosal surfaces.可溶性模式识别分子：气道黏膜表面稳态的守护者和调节剂。
Eur J Immunol. 2020 May;50(5):624-642. doi: 10.1002/eji.201847811.
2
Meeting the Challenge of Identifying New Treatments for Type 2-Low Neutrophilic Asthma.应对识别2型低嗜中性粒细胞性哮喘新疗法的挑战。
Chest. 2020 Jan;157(1):26-33. doi: 10.1016/j.chest.2019.08.2192. Epub 2019 Sep 13.
3
Validation of Asthma Control Assessment Among Urban Adolescents Using the Asthma Control and Communication Instrument.利用哮喘控制和交流工具对城市青少年的哮喘控制评估进行验证。
J Allergy Clin Immunol Pract. 2019 Mar;7(3):962-968.e1. doi: 10.1016/j.jaip.2018.10.001. Epub 2018 Oct 11.
Zotero 插件